Daniel Woolson - 06 Mar 2023 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
VP, GM-Infusion Capital
Signature
By: Paula Darbyshire, Attorney-in-fact For: Daniel Woolson
Issuer symbol
ICUI
Transactions as of
06 Mar 2023
Net transactions value
-$307,956
Form type
4
Filing time
08 Mar 2023, 16:09:27 UTC
Previous filing
02 Feb 2023
Next filing
01 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 +1,417 +15% $0.000000 10,569 06 Mar 2023 Direct
transaction ICUI Common Stock Tax liability $100,942 -626 -5.9% $161.25 9,943 06 Mar 2023 Direct
transaction ICUI Common Stock Options Exercise $0 +965 +9.7% $0.000000 10,908 07 Mar 2023 Direct
transaction ICUI Common Stock Tax liability $67,397 -428 -3.9% $157.47 10,480 07 Mar 2023 Direct
transaction ICUI Common Stock Options Exercise $0 +2,020 +19% $0.000000 12,500 08 Mar 2023 Direct
transaction ICUI Common Stock Tax liability $139,616 -894 -7.2% $156.17 11,606 08 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 -965 -33% $0.000000 1,932 07 Mar 2023 Common Stock 965 $0.000000 Direct F1, F2, F3, F4
transaction ICUI Performance Shares Options Exercise $0 -2,020 -50% $0.000000 2,020 08 Mar 2023 Common Stock 2,020 $0.000000 Direct F5, F6
transaction ICUI Performance Shares Options Exercise $0 -1,417 -100% $0.000000* 0 06 Mar 2023 Common Stock 1,417 Direct F5, F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are Restricted Stock Units.
F2 There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F3 One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F4 These are restricted stock units that fully vest 3 years from the grant date.
F5 These Securities are Performance-based Restricted Stock Units (PRSU).
F6 These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant.
F7 There is neither a purchase price nor an exercise price for the PRSUs.
F8 These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.